Karen White
Monash Institute of Pharmaceutical Sciences
2 papers found
Refreshing results…
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1
UploadMissing publications? Search for publications with a matching author name.